ARTICLE | Top Story
FDA approves denosumab for SREs
November 19, 2010 2:00 AM UTC
FDA approved an sBLA from Amgen Inc. (NASDAQ:AMGN) for Xgeva denosumab to prevent skeletal-related events in patients with bone metastases from solid tumors. Denosumab is already approved in the U.S. ...